Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Increased Nasal Fluids-Serum Concordance of Protein Profile with Prognosis in Nasal Polyps. | J Inflamm Res | 2026 | 41717500 | PubTator, text mining | PubMed |
| Interactions of bile acids and gut microbiota modulate neurological health: a comprehensive review on mechanisms and therapeutic potential of dietary phytochemicals. | Front Microbiol | 2026 | 41716273 | PubTator, text mining | PubMed |
| CAR-T cell immunotherapy in rhabdomyosarcoma. | J Transl Med | 2026 | 41709231 | PubTator, text mining | PubMed |
| Causal relationship between 91 inflammatory factors and fetal growth restriction: a bidirectional Mendelian randomization study. | J Matern Fetal Neonatal Med | 2026 | 41702666 | PubTator, text mining | PubMed |
| Interplay Between Fibroblast Growth Factor-19, Beta-Klotho, and Receptors Impacts Cardiovascular Risk in Chronic Kidney Disease. | J Clin Med | 2026 | 41682686 | PubTator, text mining | PubMed |
| FGF19/FGFR4/KLB signaling participate in the ferroptosis regulation of hepatocellular carcinoma. | Arab J Gastroenterol | 2026 | 41654439 | PubTator, text mining | PubMed |
| Plasma proteome mendelian randomization and network pharmacology reveal therapeutic targets for thyroid disorders. | Mol Cell Endocrinol | 2026 | 41616832 | PubTator, text mining | PubMed |
| Advances in pharmacological interventions for hepatic fibrosis: from pathogenic mechanisms to novel therapeutic targets. | Ann Med | 2026 | 41588833 | PubTator, text mining | PubMed |
| Mutational patterns and ancestry-linked profiles in a large hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma cohort. | ESMO Open | 2026 | 41564818 | PubTator, text mining | PubMed |
| Characterization of ESR1 alterations in patients with breast and gynecologic cancers. | Breast Cancer Res | 2026 | 41555446 | PubTator, text mining | PubMed |
| A novel oncogenic nonsense mutation of SMARCA4 and genetic characteristic analysis of SMARCA4 (BRG1)-deficient undifferentiated tumor of the bladder. | Virchows Arch | 2026 | 41555058 | PubTator, text mining | PubMed |
| Duodenal mucosal intervention in the management of MASLD and type 2 diabetes. | Diabetol Metab Syndr | 2026 | 41535957 | PubTator, text mining | PubMed |
| Body mass index mediates the association between serum fibroblast growth factor-19 and diabetes. | J Diabetes Metab Disord | 2026 | 41522208 | PubTator, text mining | PubMed |
| Navigating second-line therapy after immunotherapy in advanced HCC☆. | JHEP Rep | 2026 | 41503573 | PubTator, text mining | PubMed |
| Detection of Multi-analytes Using Luminex Multiplex Bead Immunoassay. | Methods Mol Biol | 2026 | 41478963 | PubTator, text mining | PubMed |
| Association of circulating immune cell phenotypes and peripheral inflammatory biomarkers with depressive symptoms in the Framingham Heart Study. | Psychoneuroendocrinology | 2026 | 41349492 | PubTator, text mining | PubMed |
| FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities. | Theranostics | 2026 | 41328353 | PubTator, text mining | PubMed |
| Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti-AChR Antibody-Positive Myasthenia Gravis: FGF-19 as a Novel Biomarker. | Ann Clin Transl Neurol | 2026 | 41310415 | PubTator, text mining | PubMed |
| Dysregulated inflammatory cytokines in MSM living with HIV who exhibited suboptimal immune reconstitution despite antiretroviral therapy (ART). | Cytokine | 2026 | 41297091 | PubTator, text mining | PubMed |
| Lipid-Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial-Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial Cancer. | Adv Sci (Weinh) | 2026 | 41270216 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=6